The MarketWatch News Department was not involved in the creation of this content. HOLLISTON, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the "Company" or ...

HOLLISTON, Mass. (AP) — HOLLISTON, Mass. (AP) — Harvard Bioscience Inc. (HBIO) on Monday reported a loss of $50.3 million in its first quarter. The Holliston, Massachusetts-based company said it had a ...

Harvard Bioscience (NASDAQ:HBIO) is set to give its latest quarterly earnings report on Monday, 2025-05-12. Here's what investors need to know before the announcement. Analysts estimate that Harvard ...

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates ...

Equities researchers at StockNews.com started coverage on shares of Harvard Bioscience (NASDAQ:HBIO – Get Free Report) in a research note issued to investors on Tuesday. The firm set a “hold” rating ...

Good day, and welcome to the First Quarter 2025 Harvard Bioscience Inc Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Please note this event is being ...

Harvard Bioscience, the lab equipment manufacturer based in Holliston, has signed a distribution agreement with Fisher Scientific, the large life science and clinical research firm based in Waltham.

Completes Repayment of Existing Credit Agreement, Extends Debt Maturity, and Enhances Financial Flexibility BroadOak Partner Bill Snider to Join Board of Directors and Company to Form Advisory Board ...

HOLLISTON, Mass. (AP) — HOLLISTON, Mass. (AP) — Harvard Bioscience Inc. (HBIO) on Monday reported a loss of $2.3 million in its second quarter. The Holliston, Massachusetts-based company said it had a ...

Harvard Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.02. Operator: Good day, and welcome to the First Quarter 2025 Harvard Bioscience Inc Earnings ...